HFA Premium Access

GRAND DEBATE I - Drugs or interventions - The beat goes on

Event: Heart Failure 2018 & World Congress on Acute Heart Failure
Topic: Treatment, Other
Session type: Debate Session
Date: 26 May 2018
Time: 14:45 - 16:15

Session

16 presentations in this session

Positioning of the topic

Speaker: Professor E. Braunwald (Boston, US)
Thumbnail

Coronary revascularisation provides no meaningful clinical benefit over optimal medical therapy in patients with stable ischaemic heart failure - PRO

Speaker: Professor J. Cleland (Glasgow, GB)
Thumbnail

Coronary revascularisation provides no meaningful clinical benefit over optimal medical therapy in patients with stable ischaemic heart failure - CONTRA

Speaker: Professor E. Velazquez (New Haven, US)
Thumbnail

Rebuttal - PRO

Thumbnail

Rebuttal - CONTRA

Thumbnail

Conclusion and take home message

Speaker: Professor E. Braunwald (Boston, US)
Thumbnail

Positioning of the topic

Speaker: Professor F. Ruschitzka (Zurich, CH)
Thumbnail

Opening question

Thumbnail

8 speakers from this session

Professor Eugene Braunwald

Brigham And Women'S Hospital, Harvard Medical School, Boston (United States of America)
33 presentations
0 follower

Professor John Cleland

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)
56 presentations
2 followers

Professor Eric Velazquez

Yale University, New Haven (United States of America)
7 presentations
0 follower

Professor Eugene Braunwald

Brigham And Women'S Hospital, Harvard Medical School, Boston (United States of America)
33 presentations
0 follower

Professor Frank Ruschitzka

University Heart Center, Zurich (Switzerland)
81 presentations
2 followers

Professor Nassir Marrouche

Tulane University, New Orleans (United States of America)
22 presentations
0 follower

Doctor Milton Packer

Baylor University Medical Center, Dallas (United States of America)
33 presentations
2 followers

Professor Frank Ruschitzka

University Heart Center, Zurich (Switzerland)
81 presentations
2 followers

This platform is supported by

logo Novo Nordisk